The most frequent tests done in the evaluation of patients with potential cerebrovascular disease are Oculoplethysmography (OPG) and Imaging procedures. These procedures are useful in the evaluation of asymptomatic carotid bruits and may be helpful in evaluating patients with nonhemispheric symptoms. However, there is no reasonable indication for the use of these noninvasive procedures on patients with lateralizing hemispheric or ocular transient ischemic attacks. Lateralizihg transient ischemic attacks are very often caused by ulcerated non-stenosing lesions which are easily missed by these noninvasive means. Arteriography is mandatory in this group whenever the patient is a potential surgical candidate should an appropriate lesion be found. Finally, progress made in bruit analysis is acknowledged but the clinical relevance of this datum is questioned. 
(TIA's) are not due to the restriction of blood flow imposed by a stenosis but rather to microembolization from an ulcerated plaque or some protrusion or recess in the flow path. If an ulceration is not associated with a severe stenosis, it will be missed by OPG. Therefore in TIA's, when the patient is fit for an operation, an arteriogram is mandatory whether the OPG is positive (stenosis, occlusion) or negative (possibility of ulcer ation). Given that the necessary arteriogram provides more and better information than an OPG, why are OPG's done at all in patients with TIA's?
Low-suction OPG methods (Kaitchner, Zira) could supposedly avoid arteriograms in that small number of patients who have a bruit over the bifurcation secon dary to an external carotid lesion but have a normal internal carotid artery. However, because of the noto rious unreliability of the ear lobe traces one could only forego arteriography after a scanner-obtained image shows the normal internal and stenosed external carot id arteries.
OPG-Gee 2 is a good method of obtaining retinal artery pressures. It has proven useful in anticipating the contribution of the other vessels to the flow of a hemisphere whose carotid supply is to be cut off, usu ally because of malignant disease in the neck. 3 I find the OPG-Gee a good tool to determine and document the contribution of a revascularization procedure to hemispheric (eye) pressures. This is relevant informa tion in the design and study of new surgical tech niques.
OPG methods are also used in the workup of pa tients with non-hemispheric ischemic brain symptoms. Patients with these symptoms are often referred to vas cular laboratories before completing a medical workup to rule out the far more frequent medical causes of vertebrobasilar insufficiency such as orthostatism, medication, or cardiac problems. The OPG is done in these patients to see if a stenosing carotid lesion might explain the symptoms. The trouble is that in patients without lateralizing symptoms only a minority will have extracranial carotid or vertebral disease as the cause of their symptoms. Those with severe carotid stenoses will be identified but the rare patients with pure vertebral artery disease will be missed because of negative OPG's, and, indeed, normal carotid arteries. 4 It is probably sensible to use OPG as a screening test in these patients to uncover a silent and severe internal carotid stenosis but only after the more common and non-arterial causes of vertebrobasilar insufficiency have been investigated. In the event of a normal OPG, the possibility of pure vertebral disease can only be ruled out by angiography.
Oculoplethysmography is, without a doubt, useful in the followup of carotid endarterectomies, where it can pick up lesions such as restenosis secondary to intimal hyperplasia. Also, and particularly in conjunc tion with an imaging procedure, it can reassure us that an asymptomatic neck bruit is of external rather than internal carotid origin. On the other hand, the very tight (98% or so) stenotic lesions, those one might like to know about in a hurry, are precisely the ones likely to be silent and thus go undetected. One must then conclude that the estima tion of lumen diameter within ± 1 mm is a datum of little relevance in making a clinical decision.
Imaging
In summary, a few treatment decisions can be made by using noninvasive methods in the management of patients with potential cerebrovascular disease. The main use of these methods in clinical practice is the identification of a bruit as being of an external or internal carotid source and the detection of postoper ative carotid artery abnormalities, mostly restenosis. Screening for occult severe carotid lesions before an operation involving blood loss or hypotension can be done with the OPG although the translation of a posi tive finding into a new treatment plan is still in ques tion. In patients with lateralizing TIA's noninvasive methods do hot add anything but delay to the informa tion given by a good quality 4-vessel arteriogram which is mandatory if the patient is fit for an operation. In patients with non-lateralizing TIA's the more com mon medical causes should be investigated before hand. In this group the noninvasive tests will be con clusive only when they are positive and prompt an arteriogram.
The clinical and commercial interest in these nonin vasive techniques has produced sophisticated equip ment capable of giving lis valuable information until now lacking: data on the natural history of a lesion and its modifications by various treatments. The combina tion of B-mode ultrasound and pulsed gated Doppler may provide important information on the rate of growth and possibly the regression of carotid lesions now that these outlines can be obtained with good optical resolution. This basic information is needed but, for the time being, it is research information and not for day-to-day clinical management.
It is pertinent to remember that the considerations just made presume good technique and understanding of the basic pathology and anatomy involved. Unfortu nately, some of these noninvasive tests are done by a person whose basic experience was acquired in a 2 or 3-week familiarization course given by the manufac turer of the equipment. The test may then be read by a physician who only remotely supervised it. Under these conditions the limited but undeniable usefulness of these tests becomes a liability since false negative and false positive reporting will increase.
From my perspective as a surgeon, what is happen ing to noninvasive techniques has a certain similarity to that which followed the advent of electromagnetic flow meters. We thought then that they provided an essential measure to any arterial reconstruction. We quoted Lord Kelvin's aphorism often and recorded faithfully flow rate data and waveforms before and after arterial reconstructions. Even a new nounflowmetry -was coined. We learned about wave forms and flow rates under various conditions but in general we failed to show that the addition of a single flow datum could indicate an operation or predict its outcome. The market interest in flow meters, howev er, resulted in reliable machines which are today in valuable in our experimental laboratories.
I anticipate a similar outcome for much of the nonin vasive instrumentation. It will be used in larger centers where patients are referred for difficult diagnostic problems and where it is necessary to document the hemodynamic effects of new procedures or study spe cific changes in accessible arteries. Disillusion with some of the claims made and improvements in comput er-enhanced intravenous arteriography -in itself, not a panacea -will give noninvasive tools a smaller but well deserved place in larger medical centers but out side of day-to-day clinical practice where I believe they are used in excess. 
To the Editor:
The paper by Berguer represents a particular school of thought con cerning noninvasive carotid testing which is considerably out of date. The author's point that the validity of noninvasive test results depends upon good technique as well as an understanding of the basic pathology and anatomy involved is a good one and an important one. His implicit advice that noninvasive laboratories be closely supervised by physicians is equally sound. Beyond those two points, however, I find little with which to agree with, and many gaps in Dr. Berguer's knowledge.
First and foremost, the natural history of carotid disease is not "re search information . . . not for day-to-day clinical management." It is most critical for management of patients. There is for instance, no proof that ulcerated carotid lesions embolize, except rarely, in the absence of significant stenosis. In many patients in whom a TIA or stroke is attributed to such a lesion, the source of embolus is in reality the aortic arch, a left ventricular mural thrombus from an undetected earlier myo cardial infarction, the left atrium from undetected rheumatic heart dis ease, or the mitral valve itself, with unappreciated mitral prolapse, to name a few relatively common proximal sites of thromboembolism. The angiogram is perhaps a poor way to detect mural ulceration anyway, since a thrombus-filled ulcer will not show as a defect on the angiogram, while an empty ulcer crater shows nicely but contains no thrombus! Our workup is changed by the knowledge that a patient, symptomatic or asymptomatic, has a lesion with a 1.5 mm rather than a 2.7 mm residual lumen diameter. The 1.5 mm lesion is a potential threat even if asymptomatic while the 2.7 mm lesion is hardly ever a source of symp- Oculoplethysmography is a relatively insensitive indirect method of carotid diagnosis. Spectral bruit analysis, by contrast, has improved markedly since the 5 and 8 year old studies cited by the author. In a more recent direct comparison with pathologic specimens, 1 it was accurate to within 0.5 mm in 94% of 33 patients in whom analyzable bruits were present. In the same study, selective carotid angiography was accurate to within 0.5 mm in 35 of 37 studies in which analyzable films were obtained. Thus, angiograms were not significantly more accurate than spectral bruit analysis in a blinded comparison, a point of which Dr. Berguer seems to be unaware. Furthermore, of the 39 patients in that study, 6 had spectral bruit analyses which could not be analyzed, but the technique entailed no risk, no discomfort and little expense. By con trast, 2 patients had angiograms which could not be analyzed, and 2 more had stenoses which were ± 1 mm different from the estimated value -information gained at measurable risk of stroke, considerable discomfort and much expense. Dr. Berguer may prefer angiography; most patients would prefer accurate noninvasive techniques.
Two clinical points deserve comment. First, what on earth is a nonlateralizing TIA. Second, the 98% stenosis is hardly "likely to be silent and thus go undectected.'' It usually makes a spectacular, high-pitched, almost continuous bruit. Furthermore, duplex doppler ultrasound is highly accurate in detecting lesions in such cases 2,3 and one seldom uses a single noninvasive method to evaluate a patient. 4 In summary, carotid atherosclerosis need not be operated on simply because it is present. Knowledge of its natural history is important because it teaches us that most patients with carotid atherosclerosis have no symptoms from it, and that patients with neurological symptoms and carotid disease 
Elsewhere in this issue, Dr. Ramon Berguer indicates that carotid artery noninvasive testing is being overused. One theme of his presenta tion is that hemispheric or monocular transient ischemic attacks are frequently caused by ulcerating nonstenosing lesions, and that these lesions are easily missed by the various noninvasive techniques. To the contrary, Busuttil and his colleagues reported that the incidence of transient ischemic attack and stroke is low, in patients with carotid lesions of no hemodynamic consequence. 1 These investigators used the OPG-Gee to define the presence or absence of unilateral or bilateral carotid lesions of pressure-significance, as defined by Berguer and Hwang. 2 An overall accuracy of 98% has recently been published for this technique. 3 Another theme in the remarks by Dr. Berguer is that CNS symptoms which are neither hemispheric nor monocular have multiple causes other than a carotid etiology. However, if the symptoms are due to a silent severe carotid stenosis, thrombotic occlusion and stroke can occur, while the patient is being evaluated for a suspected noncarotid cause. In this group of patients the OPG-Gee is used as a preliminary screening device, much as is the ECG in patients with chest pain.
As noted by Dr. Berguer, the literature abounds with papers on a variety of noninvasive tests for the evaluation of carotid disease. The OPG-Gee was designed with a single purpose, the simultaneous assess ment of the quantitative physiology of the entirety of both carotid arterial hemisystems, including variations induced by cardiac function. 4 Although Dr. Berguer does distinguish the various forms of ocular plethysmography somewhat, no other OPG duplicates the function of the OPG-Gee, nor does any other form of noninvasive carotid evalua tion. It was designed for simplicity of application, rapidity of testing (less than one minute) and ease of interpretation. Dr. Berguer concludes by observing that the initial enthusiastic claims for intravenous digital subtraction angiography (IDSA) are somewhat premature, but that improvements are both possible and expected. Strother and Crummy, early proponents of IDSA, have also urged caution in this regard. 5 In addition, they noted "the fact that clinical manifestations of thrombo-embolic stroke are, for the most part, related more to physiological changes than to disturbed anatomy . . . .", an observation with which I agree (underlining is mine).
In summary, the following is a recommended algorithm. In the asymptomatic patient with an increased likelihood of carotid atheroscle rosis (coronary or peripheral atherosclerosis, carotid bruit, neck radi ation) an OPG-Gee study is done at six-month intervals. If the initial or any subsequent test is positive, standard arteriography is recommended. In the symptomatic patient (global, hemispheric, monocular, binocular, vertebro-basilar) with a positive OPG-Gee, standard arteriography is recommended. In the patient with hemispheric or monocular symptoms and a negative OPG-Gee, standard arteriography is recommended. In the group of patients with global or vertebra basilar symptoms and a negative OPG-Gee, our experience has shown the highest incidence of cardiac dysrhythmiae. One of the four channels of the OPG-Gee record carries the simultaneous ECG. It is amazing to see the profound alter ation in oculovascular dynamics associated with what superficially ap pear to be minor cardiac dysrhythmiae. Some of these problems are treated with the implantation of ventricular demand pacemakers. Our experience has documented that in somewhat over one-quarter of pa tients so treated, little improvement is noted. The lack of improvement is directly attributable to pacemaker effect, and conversion to atrioven tricular sequential pacing corrects the deficiency.
Standard arteriography in our community hospital has a mortality of less than 0.1% and a morbidity of less than 1.0%. The unsurpassed anatomic definition afforded by this technique, coupled with the physio logic assessment provided by the OPG-Gee, remains our primary meth od, for the present. A combination of the OPG-Gee and IDSA, both as outpatient procedures, may reduce the inpatient requirement for stan dard arteriography, in the future.
